ARC Medical Inc.

We’re thrilled to announce that three of ARC Medical Inc.'s esteemed team members (Chris Springate, Aileen Yang, Roy Jackson) will be attending the 2024 CanSAGE Annual Conference, taking place from September 26-28 in Victoria, British Columbia. This year’s theme, “Transforming Tomorrow: Improving Access to Advanced Gynecologic Care,” aligns perfectly with ARC Medical's mission to drive innovative solutions in preventing adhesions resulting from gynecological surgery. Join us as our experts take part in this prestigious event, which brings together leading clinicians and researchers to share cutting-edge advancements in minimally invasive gynecologic surgery. It’s an outstanding opportunity to explore the latest trends in managing complex gynecologic conditions, and we're excited to be part of the conversation. Whether you're attending in person or virtually, we look forward to connecting with colleagues and continuing to push the boundaries of what's possible in gynecological care. #CanSAGE2024 #health #healthcare #entrepreneurship #ceo #venturecapital

Chris Springate, CEO of ARC Medical Inc., was an invited speaker in a recent panel discussion at the LSX - partnering for Life Science eXecutives conference on  "Medtech Payoff: The Foundations of Successful Payer Relationships." Dr. Springate and the other speakers ( Georgia Mitsi, Carolina Aguilar, Christian Howell and Willem Baralt) discussed the challenges medical device startups face in navigating the US healthcare reimbursement system. Conclusions from the discussion were that:   1) Startups need to take into account reimbursement and payer relationships early in the product design process.   2) Companies must understand the needs of various payers, including commercial payers and CMS; and the relationships between those payers with hospitals and ambulatory surgical centers. It's critical to gather evidence of product effectiveness and cost savings to convince payers to cover the product.   3) Startups must also consider collaborating with regulatory bodies like the FDA and CMS early on to streamline the market and reimbursement approval processes.   4) Lastly, designing products that address large unmet medical needs, reduce costs, and improve patient outcomes is crucial for success in the market.   #health #healthcare #entrepreneurship #ceo #venturecapital

Having successfully deployed JOCOAT™ in orthopedic surgical patients, ARC Medical Inc. will be sharing the story of our novel fluid medical devices in clinical development for the prevention of surgical adhesions at several prestigious events in the months ahead.  https://lnkd.in/gBuucuKj #health #healthcare #entrepreneurhip #ceo #venturecapital

ARC Medical Inc.'s CEO Chris Springate will be presenting ARC's innovative device for preventing surgical adhesions at next week's Bullpen Pitch Fest. Connect with Chris if you'll be in the area! https://lnkd.in/gnvUZJmJ

ARC Medical Inc.'s CEO Chris Springate will be presenting this week at the 10th LSX World Congress in London. Please join his ARC strategy presentation or his panel discussion if you'll be at the Congress! https://lnkd.in/gyhrQPde

ARC Medical Inc. is excited to be a part of the LSI USA '24 Emerging Medtech Summit, medtech's premier partnering event. At the summit, our CEO Chris Springate will be presenting ARC's exciting plans in addressing surgical adhesions with our novel fluid medical devices. The conference, held in Dana Point, California, will be attended by medtech's leading innovators, investors and strategics. If you're attending, please be sure to connect with Chris. A heartfelt shoutout to the entire team at LSI for curating such an impactful gathering. Their dedication and vision ensures their events remain benchmarks in the industry year after year. #LSIUSA24 #LSIAlumni #medtech #venturecapital #ceo #healthtech

Journalist Sakchi Khandelwal wrote a crisp but thoughtful review in BBN Breaking News (https://lnkd.in/giQpDB6Z) of ARC Medical Inc.'s progress and plans in addressing a significant unmet medical need through the development of an innovative fluid medical device to prevent surgical adhesions. She described the application of the platform across four separate devices; and she outlined ARC's outreach to better inform clinical and financial audiences about the plans. Thank you, Sakchi, for an insightful summary of our work. #health #healthcare #entrepreneurship #ceo #venturecapital https://lnkd.in/gkUyneGu

Journalist Phalguni Deswal published an informative article in Medical Device Network and Clinical Trials Arena that outlines ARC Medical Inc.'s clinical plans. Through an interview with ARC's CEO Chris Springate, she discussed in detail our novel fluid medical device in development for the prevention of surgical adhesions in multiple indications. The article appeared just as ARC is announcing an ambitious program of events to better inform partners, investors and collaborators about our differentiated technology and development plans. #health #healthcare #entrepreneurship #ceo #venturecapital https://lnkd.in/g8D3Wczk

Today we announced ARC Medical Inc. ambitious plan to engage with current and prospective partners, investors and collaborators at a serious of events during the first half of 2024. Please check out our press release. Feel free to plan a visit with a senior member of ARC's team if you will be at any of the events! #health #healthcare #entrepreneurship #ceo #venturecapital https://lnkd.in/dieE5GFk

We're pleased and proud to be highlighted by LSI for the first deployment in patients of our novel fluid medical device JOCOAT™ for the prevention of surgical adhesions - thank you LSI!